L LLY

Lilly(Eli) & Company

DRUG MANUFACTURERS - GENERAL · HEALTHCARE

Eli Lilly and Company (Ticker: LLY), headquartered in Indianapolis, Indiana, is a leading global pharmaceutical entity distinguished for its cutting-edge advancements in healthcare. The company primarily concentrates on therapeutic areas including diabetes, oncology, and neurodegenerative diseases, ...

$1,417.54

+3.19% (+$43.84)

Volume 5.25M

52W High $1,449.68

52W Low $834.19

Market Cap $1.24T

← Back to Calendar Compare with Others →

Next Earnings Report

Last Reported

Oct 29, 2026 Beat

Actual: $7.48 vs. Consensus: $5.38

Price Chart

EPS History: Consensus vs Actual

Last 12 quarters

Price Movement Around Earnings

Q3 2026 Oct 29, 2026

1-Day: +3.19%

Q2 2026 Aug 5, 2026

1-Day: +1.89%

5-Day: +5.31%

Q1 2026 Apr 30, 2026

1-Day: +3.07%

5-Day: +5.81%

Q4 2025 Feb 11, 2026

1-Day: +2.27%

Revenue & Financial Performance

Quarter	Revenue	YoY Growth	Gross Margin	Op Margin	Net Income
Q3'26	$24.40B	+38.6%	83.9%	35.3%	$6.45B
Q2'26	$22.97B	+47.7%	85.8%	54.2%	$7.10B
Q1'26	$19.80B	+55.5%	81.9%	49.4%	$7.40B
Q4'25	$19.29B	+42.6%	82.5%	46.6%	$6.64B
Q3'25	$17.60B	+53.9%	82.9%	47.7%	$5.58B
Q2'25	$15.56B	+37.7%	84.3%	45.1%	$5.66B
Q1'25	$12.73B	+45.2%	82.5%	41.7%	$2.76B
Q4'24	$13.53B	+44.7%	82.2%	42.0%	$4.41B

Historical Earnings

Last 12 quarters

Quarter	Date	Consensus	Whisper	Actual EPS	Surprise %	Result
Q3 2026	Oct 29, 2026	$5.38	$7.16	$7.48	+39.03%	Beat
Q2 2026	Aug 5, 2026	$6.01	$7.23	$8.38	+39.43%	Beat
Q1 2026	Apr 30, 2026	$6.79	$7.15	$8.55	+25.92%	Beat
Q4 2025	Feb 11, 2026	$7.17	$7.45	$7.54	+5.16%	Beat
Q4 2025	Feb 4, 2026	$7.17	$7.49	$7.54	+5.16%	Met
Q3 2025	Oct 30, 2025	$5.89	$6.36	$7.02	+19.19%	Beat
Q2 2025	Aug 7, 2025	$5.61	$5.83	$6.31	+12.48%	Beat
Q1 2025	May 1, 2025	$3.46	$3.79	$3.34	-3.47%	Missed
Q4 2024	Feb 6, 2025	$5.07	$5.44	$5.32	+5.00%	Missed
Q3 2024	Oct 30, 2024	$1.47	$1.69	$1.18	-19.73%	Missed
Q2 2024	Aug 8, 2024	$2.77	$2.99	$3.92	+41.52%	Beat
Q1 2024	Apr 30, 2024	$2.49	$2.83	$2.58	+3.61%	Missed